Literature DB >> 11164612

Bacillus intermedius ribonuclease as inhibitor of cell proliferation and membrane current.

O Ilinskaya1, K Decker, A Koschinski, F Dreyer, H Repp.   

Abstract

The antiproliferative action of the guanine-specific ribonuclease secreted by Bacillus intermedius (binase) was studied in different chicken and mouse cell lines. The proliferation rate of chicken embryo fibroblasts, either normal or Rous sarcoma virus-transformed, was significantly reduced by binase treatment. Among mouse fibroblasts, v-ras-transformed NIH3T3 cells were sensitive to binase, whereas the growth of non-transformed, v-src-transformed or v-fms-transformed NIH3T3 cells was not affected. A 48 h treatment with binase inhibited the Ca2+-dependent K+ current of v-ras-transformed NIH3T3 cells but had no effect on this membrane current in non-transformed and in v-src- or v-fms-transformed NIH3T3 cells. Our results suggest that mammalian cells expressing the ras-oncogene are a potential target for the antiproliferative action of binase.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11164612     DOI: 10.1016/s0300-483x(00)00335-8

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  15 in total

1.  Changing the net charge from negative to positive makes ribonuclease Sa cytotoxic.

Authors:  Olga N Ilinskaya; Florian Dreyer; Vladimir A Mitkevich; Kevin L Shaw; C Nick Pace; Alexander A Makarov
Journal:  Protein Sci       Date:  2002-10       Impact factor: 6.725

Review 2.  Microbial ribonucleases (RNases): production and application potential.

Authors:  E Esin Hameş; Tuğçe Demir
Journal:  World J Microbiol Biotechnol       Date:  2015-10-03       Impact factor: 3.312

3.  Bovine Pancreatic RNase A: An Insight into the Mechanism of Antitumor Activity In Vitro and In Vivo.

Authors:  Islam Saber Ead Mohamed; Aleksandra V Sen'kova; Oleg V Markov; Andrey V Markov; Innokenty A Savin; Marina A Zenkova; Nadezhda L Mironova
Journal:  Pharmaceutics       Date:  2022-05-30       Impact factor: 6.525

Review 4.  Evasion of ribonuclease inhibitor as a determinant of ribonuclease cytotoxicity.

Authors:  Thomas J Rutkoski; Ronald T Raines
Journal:  Curr Pharm Biotechnol       Date:  2008-06       Impact factor: 2.837

Review 5.  Ribonucleases as potential modalities in anticancer therapy.

Authors:  Wojciech Ardelt; Barbara Ardelt; Zbigniew Darzynkiewicz
Journal:  Eur J Pharmacol       Date:  2009-10-14       Impact factor: 4.432

6.  Ribonuclease binase inhibits primary tumor growth and metastases via apoptosis induction in tumor cells.

Authors:  Nadezhda L Mironova; Irina Y Petrushanko; Olga A Patutina; Aexandra V Sen'kova; Olga V Simonenko; Vladimir A Mitkevich; Oleg V Markov; Marina A Zenkova; Alexander A Makarov
Journal:  Cell Cycle       Date:  2013-06-10       Impact factor: 4.534

Review 7.  Discovery of antitumor effects of leczymes.

Authors:  Takeo Tatsuta; Masahiro Hosono
Journal:  Glycoconj J       Date:  2022-01-23       Impact factor: 2.916

8.  Gel-based oligonucleotide microarray approach to analyze protein-ssDNA binding specificity.

Authors:  Olga A Zasedateleva; Andrey L Mikheikin; Alexander Y Turygin; Dmitry V Prokopenko; Alexander V Chudinov; Elena E Belobritskaya; Vladimir R Chechetkin; Alexander S Zasedatelev
Journal:  Nucleic Acids Res       Date:  2008-05-12       Impact factor: 16.971

9.  MicroRNA drop in the bloodstream and microRNA boost in the tumour caused by treatment with ribonuclease A leads to an attenuation of tumour malignancy.

Authors:  Nadezhda Mironova; Olga Patutina; Evgenyi Brenner; Alexander Kurilshikov; Valentin Vlassov; Marina Zenkova
Journal:  PLoS One       Date:  2013-12-30       Impact factor: 3.240

10.  Antitumor Macrophage Response to Bacillus pumilus Ribonuclease (Binase).

Authors:  Anna Makeeva; Julian Rodriguez-Montesinos; Pavel Zelenikhin; Alexander Nesmelov; Klaus T Preissner; Hector A Cabrera-Fuentes; Olga N Ilinskaya
Journal:  Mediators Inflamm       Date:  2017-05-18       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.